These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2220561)

  • 1. Update on quinolone drug interactions.
    Hulisz D; Miller K
    Am Pharm; 1990 Sep; NS30(9):34-6. PubMed ID: 2220561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-drug interactions with ciprofloxacin and other fluoroquinolones.
    Polk RE
    Am J Med; 1989 Nov; 87(5A):76S-81S. PubMed ID: 2686430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antacid interaction with new quinolones: dose regimen recommendations based on pharmacokinetic modeling of clinical data for ciprofloxacin, gatifloxacin and norfloxacin and metal cations.
    Miyata K; Ohtani H; Tsujimoto M; Sawada Y
    Int J Clin Pharmacol Ther; 2007 Jan; 45(1):63-70. PubMed ID: 17256452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K
    Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin.
    Nix DE; Watson WA; Handy L; Frost RW; Rescott DL; Goldstein HR
    Pharmacotherapy; 1989; 9(6):377-80. PubMed ID: 2616352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
    Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
    Drugs; 1987; 34 Suppl 1():159-69. PubMed ID: 3481317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.
    Barnett G; Segura J; de la Torre R; Carbó M
    Eur J Clin Pharmacol; 1990; 39(1):63-9. PubMed ID: 2177401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-quinolones inhibit biotransformation of caffeine.
    Harder S; Staib AH; Beer C; Papenburg A; Stille W; Shah PM
    Eur J Clin Pharmacol; 1988; 35(6):651-6. PubMed ID: 2853056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of quinolone antimicrobials on theophylline pharmacokinetics.
    Prince RA; Casabar E; Adair CG; Wexler DB; Lettieri J; Kasik JE
    J Clin Pharmacol; 1989 Jul; 29(7):650-4. PubMed ID: 2760258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials.
    Nix DE; DeVito JM
    Clin Pharm; 1987 Feb; 6(2):105-17. PubMed ID: 3311572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.
    Well M; Naber KG; Kinzig-Schippers M; Sörgel F
    Int J Antimicrob Agents; 1998 Apr; 10(1):31-8. PubMed ID: 9624541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Sucralfate on the Relative Bioavailability of Enrofloxacin and Ciprofloxacin in Healthy Fed Dogs.
    KuKanich K; KuKanich B; Guess S; Heinrich E
    J Vet Intern Med; 2016; 30(1):108-15. PubMed ID: 26651022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of norfloxacin on theophylline pharmacokinetics at steady state.
    Bowles SK; Popovski Z; Rybak MJ; Beckman HB; Edwards DJ
    Antimicrob Agents Chemother; 1988 Apr; 32(4):510-2. PubMed ID: 3377462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of a new tetracyclic quinolone, No. 5290, against norfloxacin- and ciprofloxacin-resistant strains of Staphylococcus aureus.
    Kotera Y; Inoue Y; Ohashi M; Ito K; Tsukamoto G
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2644-6. PubMed ID: 1666861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions of ciprofloxacin with other non-antibiotic agents.
    Rubinstein E; Segev S
    Am J Med; 1987 Apr; 82(4A):119-23. PubMed ID: 3555026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes.
    Sarkar M; Polk RE; Guzelian PS; Hunt C; Karnes HT
    Antimicrob Agents Chemother; 1990 Apr; 34(4):594-9. PubMed ID: 2344166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sucralfate on absorption of norfloxacin and ofloxacin.
    Lehto P; Kivistö KT
    Antimicrob Agents Chemother; 1994 Feb; 38(2):248-51. PubMed ID: 8192452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New synthetic quinolone antibacterial agents and serum concentration of theophylline.
    Niki Y; Soejima R; Kawane H; Sumi M; Umeki S
    Chest; 1987 Oct; 92(4):663-9. PubMed ID: 3477409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal activity of ciprofloxacin, norfloxacin and ofloxacin in serum and urine after oral administration to healthy volunteers.
    Zeiler HJ; Beermann D; Wingender W; Förster D; Schacht P
    Infection; 1988; 16 Suppl 1():S19-23. PubMed ID: 3286510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of drug interactions with the quinolones.
    Davey PG
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():97-107. PubMed ID: 3053579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.